Data / Form D filings / Cambrian BioPharma Inc
Cambrian BioPharma Inc: Form D filings
Cambrian BioPharma Inc, a biotechnology company in New York, NY, filed 6 Form D notices with the SEC between 2020 and 2026. The latest, on July 15, 2026, reports $123.8 million sold of a $129.8 million offering to 80 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 228 Park Avenue South Suite 66643, New York, NY, 10003
- Phone
- (516) 962-3186
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1797409
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | New notice | $129,751,064 | $123,751,064 | $6,000,000 | 80 | Jun 30, 2026 | sec.gov |
| Jan 13, 2025 | Amendment | $37,602,297 | $23,022,065 | $14,580,232 | 30 | Jun 2, 2023 | sec.gov |
| Dec 22, 2023 | New notice | $40,000,000 | $7,691,833 | $32,308,167 | 20 | Jun 2, 2023 | sec.gov |
| Dec 2, 2021 | New notice | $100,775,000 | $92,209,653 | $8,565,347 | 56 | Oct 13, 2021 | sec.gov |
| May 6, 2021 | New notice | $28,434,938 | $28,434,938 | 30 | Oct 20, 2020 | sec.gov | |
| Jan 27, 2020 | New notice | $4,750,000 | $4,750,000 | 5 | Oct 29, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Peyer | Executive Officer, Director | |
| Juliette Han | Executive Officer, Director | |
| Mark Nuttall | Executive Officer | |
| Ruth Thieroff-Ekerdt | Executive Officer | |
| William DeVaul | Executive Officer | |
| Christian Angermeyer | Director | |
| Maryanna Saenko | Director | |
| Brenton L. Saunders | Director | |
| Paul Farr | Director | |
| Martin Gunhaga | Director | |
| Lorin Van Nuland | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jul 13, 2026 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cambrian BioPharma Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.